Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Jeferon vs Ribavirin for Pediatric Herpangina
NCT03266601Phase 4Completed
- Sponsor
- Children's Hospital of Fudan University
- Start
- Jun 2016
- Primary completion
- Nov 2018
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of interferon alfa-2b in herpangina (2 arms), sponsored by Children's Hospital of Fudan University. Primary endpoint: The defervesce rate during treatment by 72 hours. Started Jun 2016; status: completed.
02
Drugs
interferon alfa-2b
03
Conditions
herpangina
Beyond the preview
Go deeper on NCT03266601.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03266601.